Effects of angiotensin converting enzyme inhibition on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass

European Journal of Cardio-thoracic Surgery

Volumn 13, Issue 5, 1998, Pages 546-550

  Deakin, Charles D ^a   Dalrymple Hay, Malcolm J R ^a   Jones, Paul ^a   Monro, James L ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

ACE inhibitor; Cardiopulmonary bypass; Systemic vascular resistance

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL; RAMIPRIL; TRANDOLAPRIL;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEMODYNAMICS; HUMAN; INDUCED HYPOTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC VASCULAR RESISTANCE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPOTHERMIA, INDUCED; MIDDLE AGED; PILOT PROJECTS; REWARMING; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 0031776412     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(98)00051-7     Document Type: Article

References (22)

1. Bailey D, Miller E, Kaplan J, Rogers P. The renin-angiotensin-aldosterone system during cardiac surgery with morphine-nitrous oxide anaesthesia. Anesthesiology 1975;42:538-544.
2. Taylor K, Brannan J, Bain W, Caves P, Morton I. Role of angiotensin II in the development of peripheral vasoconstriction during cardiopulmonary bypass. Cardiovasc Res 1979;13:269-273.
3. Banas J. Effects of inhibitors of angiotensin-converting enzyme on regional hemodynamics. Am J Cardiol 1992;69:40C-45C.
4. Faxon D, Creager M, Halperin J, Bernard D, Ryan T. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Am J Med 1984;76:104-110.
5. Thaker U, Geary V, Chalmers P, Sheikh F. Low systemic vascular resistance during cardiac surgery: case reports, brief review, and management with angiotensin II. J Cardiothorac Anesth 1990; 4:360-363.
6. Tuman K, McCarthy R, O'Connor C, Holm W, Ivankovich A. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 1995; 80:473-479.
7. Matthews J, Altman D, Campbell M, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-235.
8. Boldt J, Schindler E, Härter K, Görlach G, Hempelmann G. Influence of intravenous administration of angiotensin-converting enzyme inhibitor enalaprilat on cardiovascular mediators in cardiac surgery patients. Anesth Analg 1995;80:480-485.
9. Boldt J, Knothe C, Schindler F, Stertmann W, Hempelmann G. Isolated circulatory response to intravenous administration of the ACE inhibitor enalaprilat. Br J Clin Pharmacol 1994;37:341-346.
10. Licker M, Neidhart P, Lustenberger S, Valloton M, Kalonji T, Fathi M, Morel D. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery. Anesthesiology 1996;84:789-800.
11. Taylor K, Bain W, Russel M, Brannan J, Morton I. Peripheral vascular resistance and angiotensin II levels during pulsatile and non-pulsatile cardiopulmonary bypass. Thorax 1979;34:594-598.
12. De Leeuws P, Van Der Starre P, Marinck-de-Weerde A. Humoral changes during and following coronary bypass surgery: relationship to postoperative blood pressure. J Hypertens 1983;112:52-54.
13. Weinstein G, Zabetakis P, Clavel A, Franzone A, Agrawal M, Gleim G, Michelis M, Wallsh E. The renin-angiotensin system is not responsible for hypertension following coronary artery bypass grafting surgery. Ann Thorac Surg 1987;43:74-77.
14. Taylor K, Casals J, Mittra S, Branan J, Morton J. Haemodynamic effects of angiotensin converting enzyme inhibition after cardiopulmonary bypass in dogs. Cardiovasc Res 1980;14:199-205.
15. Feddersen K, Aurell M, Delin K, Haggendal J, Aren C, Radegran K. Effects of cardiopulmonary bypass and prostacyclin on plasma catecholamines, angiotensin II and arginine vasopressin. Acta Anaesthesiol Scand 1985;29:224-230.
16. Townsend G, Wynands J, Whalley D, Wong P, Bevan D. Role of renin-angiotensin system in cardiopulmonary bypass hypertension. Can Anaesth Soc J 1984;31:160-165.
17. Goto M, Kudoh K, Minami S, Nukariya M, Sasaguri S, Watanabe M, Hosoda Y. The renin-angiotensin-aldosterone system and hematologic changes during pulsatile and non-pulsatile cardiopulmonary bypass. Artif Organs 1993;17:318-322.
18. Myles P, Olenikov I, Bujor M, Davis B. ACE inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. Med J Aust 1993;158:675-677.
19. Niarchos A, Roberts A, Case D. Hemodynamic characteristics of hypertension after coronary bypass surgery and effects of the converting enzyme inhibitor. Am J Cardiol 1979;43:586-593.
20. Colson P, Ribstein J, Mimran A. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology 1990;72:23-27.
21. Simon A, Levenson J, Safar A, Bouthier J, Safar M. ACE inhibition and brachial artery haemodynamics in hypertension. Br J Clin Pharmacol 1984;18:243S-246S.
22. Simon A, Levenson J, Bouthier J, Maarek B, Safar M. Effects of acute and chronic angiotensin-converting enzyme inhibition on larger arteries in human hypertension. J Cardiovasc Pharmacol 1985; 7:S45-S51.